Skip Navigation

Link to  the National Institutes of Health NIDA NEWS NIDA News RSS Feed
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Keep Your Body Healthy
Go to the Home pageGo to the About Nida pageGo to the News pageGo to the Meetings & Events pageGo to the Funding pageGo to the Publications page
PhysiciansResearchersParents/TeachersStudents/Young AdultsEn Español Drugs of Abuse & Related Topics

NIDA Home > Publications > Research Monographs >    

Cost-Benefit/Cost-Effectiveness Research of Drug Abuse Prevention: Implications for Programming and Policy



NIDA Research Monograph, Number 176 [Printed in 1998]

Get Adobe Reader

Complete Monograph: Monograph176.pdf (644 Kb)


Click on link to go page

Table of Contents

Introduction-----1
William J. Bukoski

The Impact of Substance Abuse on Federal Spending-----5
Jeffrey Merrill and Kimberley Fox

A Historical Perspective on Effective Prevention-----37
Richard I. Evans

School-Based Approaches to Drug Abuse Prevention: Evidence for Effectiveness and Suggestions for Determining Cost-Effectiveness-----59
Gilbert J. Botvin, Elizabeth M. Botvin, and Hirsch Ruchlin

Effectiveness of Prevention Interventions With Youth at High Risk of Drug Abuse-----83
Richard F. Catalano, Kevin P. Haggerty, Randy R. Gainey, Marilyn J. Hoppe, and Devon D. Brewer

Costs, Benefits, and Cost-Effectiveness of Comprehensive Drug Abuse Prevention-----111
Mary Ann Pentz

Overview of Methods: Cost-Effectiveness, Cost-Benefits, and Cost-Offsets of Prevention-----130
Albert Woodward

Analytic Issues for Estimating the Benefits and Costs of Substance Abuse Prevention-----141
Gary A. Zarkin and Robert L. Hubbard

Benefits and Costs of a Family-Focused Methadone Treatment and Drug Abuse Prevention Program: Preliminary Findings-----161
Robert D. Plotnick, Diane S. Young, Richard F. Catalano, and Kevin P. Haggerty

Issues and Methods in Evaluating Costs, Benefits, and Cost-Effectiveness of Drug Abuse Prevention Programs for High-Risk Youth-----184
Marsha Lillie-Blanton, Lisa Werthamer, Pinka Chatterji, Claire Fienson, and Christine Caffray

Implications for Prevention Policy: A Commentary-----214
Robert L. DuPont

Ordering Information-----222




NIDA Home | Site Map | Search | FAQs | Accessibility | Privacy | FOIA (NIH) | Employment | Print Version


National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Tuesday, July 22, 2008. The U.S. government's official web portal